Your session is about to expire
← Back to Search
Omegaven for Bone Marrow Transplant
Study Summary
This trial is testing whether fish oil lipid emulsion (FOLE), rich in omega-3 fatty acids, is safe and tolerated in children undergoing hematopoietic cell transplantation (HCT) for cancer or blood disorders.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 4 trial • 48 Patients • NCT00862446Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had a stroke, heart attack, or blood clot in the past 6 months, or you are currently being treated for any of these conditions.You are in a coma and the doctors are not sure what caused it.You are currently taking a medication called rapamycin for preventing graft-versus-host disease (GVHD).You have a condition called refeeding syndrome.You are allergic to eggs, fish, or soy/legume products.If you have a known intolerance to eggs, fish, or soy/legumes but not a documented allergy, the decision to include you in the study will be made by the doctor and you or your family.You have a medical condition that makes it unsafe for you to receive certain types of nutrition or intravenous fats.You have a high chance of getting an infection.
- Group 1: Soybean Oil Lipid Emulsion
- Group 2: Fish Oil Lipid Emulsion
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants is this trial recruiting?
"Affirmative, the information hosted by clinicaltrials.gov reveals that this research is actively recruiting patients. The trial was announced on June 1st 2016 and its parameters have been updated as recently as June 9th 2022; 20 participants need to be found from one medical facility."
In what clinical scenarios is Omegaven commonly utilized?
"Omegaven is primarily employed to tackle parenteral nutrition, yet it may also be utilized for dietary supplementation or post-natal nutritional therapies."
Are researchers still recruiting for this experiment?
"This clinical trial, posted on June 1st 2016 and updated on the 9th of last month, is actively seeking volunteers. The data available through clinicaltrials.gov reflect this."
Are there any precedents of Omegaven being implemented in other clinical trials?
"At the moment, 17 clinical trials are testing the efficacy of Omegaven. 3 of those experiments have progressed to Phase 3 and there are 32 sites offering this treatment - predominantly situated in Ciudad De Mexico, Mexico."
Does my profile fit the criteria necessary to participate in this research?
"The study is limited to children between two and eighteen years old with a hematopoietic stem cell count within the normal range. The trial will likely admit 20 participants in total."
Has the Omegaven medication been given authorization by the FDA?
"The safety rating of Omegaven was set at 1 due to the limited evidence available from this early-phase trial. There is only minimal data demonstrating its efficacy and security."
Does this trial accept participants who are younger than 65 years old?
"To participate in this medical trial, the patient's age must fall between 2 and 18 years old. Of those qualified for enrolment, 30 are younger than 18 while 41 patients have surpassed 65 years of age."
Share this study with friends
Copy Link
Messenger